Breast feeding, parity and breast cancer subtypes in a Spanish cohort

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Redondo, Carmen M ^a   Gago Domínguez, Manuela ^b   Ponte, Sara Miranda ^a   Castelo, Manuel Enguix ^a   Jiang, Xuejuan ^c   García, Ana Alonso ^d   Fernández, Maite Peña ^b   Tomé, María Ausencia ^b   Fraga, Máximo ^b   Gude, Francisco ^b   Martínez, María Elena ^e   Garzón, Víctor Muñoz ^a   Carracedo, Ángel ^b   Castelao, J Esteban ^a  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; COHORT ANALYSIS; DEMOGRAPHY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PARITY; PREGNANCY; RISK FACTOR; SPAIN; SPANISH;

ADULT; AGED; AGED, 80 AND OVER; BREAST FEEDING; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MIDDLE AGED; PARITY; PREGNANCY; RECEPTOR, ERBB-2; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RISK FACTORS; SPAIN;

EID: 84863833768     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040543     Document Type: Article

References (48)

1. Li CI, Malone KE, Daling JR, (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163: 49-56.
2. Shavers VL, Harlan LC, Stevens JL, (2003) Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35. Cancer 97: 134-147.
3. Chu KC, Anderson WF, (2002) Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74: 199-211.
4. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW, (2001) Frequency distributions of breast cancer characteristics classified by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92: 37-45.
5. Patel TA, Colon-Otero G, Bueno Hume C, Copland JA, Perez EA, (2010) Breast Cancer in Latinas: Gene Expression, Differential Response to Treatments, and Differential Toxicities in Latinas Compared with Other Population Groups. The Oncologist 15: 466-475.
6. Wojcik BE, Spinks MK, Stein CR, (2003) Effects of Screening Mammography on the Comparative Survival Rates of African American, White, and Hispanic Beneficiaries of a Comprehensive Health Care System. The Breast Journal 9: 175-183.
7. Watlington AT, Byers T, Mouchawar J, Sauaia A, Ellis J, (2007) Does having insurance affect differences in clinical presentation between Hispanic and non-Hispanic white women with breast cancer? Cancer 109: 2093-2099.
8. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, et al. (2009) Breast Cancer Risk Factors Defined by Estrogen and Progesterone Receptor Status. American Journal of Epidemiology 169: 1251-1259.
9. Martinez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA, (2010) What can we learn about disease etiology from case-case analyses? Lessons from breast cancer. Cancer Epidemiol Biomarkers Prev 19: 2710-2714.
10. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE, (2004) Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst 96: 218-228.
11. Vona-Davis L, Rose DP, (2009) The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review. J Womens Health (Larchmt) 18: 883-893.
12. Elledge RM, Clark GM, Chamness GC, Osborne CK, (1994) Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 86: 705-712.
13. Galicia Xd, (2001) Galicia in the World. The exterior action of the Xunta of Galicia. Xunta de Galicia 2001: 456-465.
14. Shetterly SM, Baxter J, Morgenstern NE, Grigsby J, Hamman RF, (1998) Higher instrumental activities of daily living disability in Hispanics compared with non-Hispanic whites in rural Colorado. The San Luis Valley Health and Aging Study. Am J Epidemiol 147: 1019-1027.
15. Martínez ME, Gutiérrez-Millan LE, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, et al. (2010) Comparative study of breast cancer in Mexican and Mexican-American women. Health 2: 1040-1048.
16. Ellis IO, Schnitt SJ, Sastre-Garau X, Bussolati G, Tavassoli FA, et al. (2003) Invasive breast carcinomas. In: Tavassoli FA, Devilee P, editors. pp. 9-110 editors. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press.
17. Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, et al. (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195-198.
18. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, et al. (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16: 439-443.
19. Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, et al. (2008) Epidemiology of basal-like breast cancer. Breast Cancer Res Treat 109: 123-139.
20. Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, et al. (2011) Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. J Natl Cancer Inst 103: 470-477.
21. Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, et al. (2011) Parity and lactation in relation to estrogen receptor negative breast cancer in African American women. Cancer Epidemiol Biomarkers Prev 20: 1883-1891.
22. Xing P, Li J, Jin F, (2010) A case-control study of reproductive factors associated with subtypes of breast cancer in Northeast China. Med Oncol 27: 926-931.
23. Phipps AI, Malone KE, Porter PL, Daling JR, Li CI, (2008) Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer. Cancer 113: 1521-1526.
24. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, et al. (2010) Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study. Cancer Res 70: 575-587.
25. Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, et al. (2009) The epidemiology of triple-negative breast cancer, including race. Cancer Causes Control 20: 1071-1082.
26. Shinde SS, Forman MR, Kuerer HM, Yan K, Peintinger F, et al. (2010) Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer. Cancer 116: 4933-4943.
27. Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, et al. (2009) Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res 11: R31.
28. Dunnwald LK, Rossing MA, Li CI, (2007) Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients. Breast Cancer Res 9: R6.
29. Hines LM, Risendal B, Slattery ML, Baumgartner KB, Giuliano AR, et al. (2008) Differences in estrogen receptor subtype according to family history of breast cancer among Hispanic, but not non-Hispanic White women. Cancer Epidemiol Biomarkers Prev 17: 2700-2706.
30. Hausauer AK, Keegan TH, Chang ET, Clarke CA, (2007) Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype. Breast Cancer Res 9: R90.
31. Symmans WF, Fiterman DJ, Anderson SK, Ayers M, Rouzier R, et al. (2005) A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. Endocrine-Related Cancer 12: 1059-1069.
32. Lapham SJ, (1993) 1990 Ethnic Profiles for States. Washington, DC: Ethnic and Hispanic Branch, Population Division, Bureau of the Census, CPH L-136.
33. Chakraborty BM, Fernandez-Esquer ME, Chakraborty R, (1999) Is being Hispanic a risk factor for non-insulin dependent diabetes mellitus (NIDDM)? Ethn Dis 9: 278-283.
34. Sans M, (2000) Admixture studies in Latin America: from the 20th to the 21st century. Hum Biol 72: 155-177.
35. Vega A, Torres M, Martinez JI, Ruiz-Ponte C, Barros F, et al. (2002) Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula. Annals of Human Genetics 66: 29-36.
36. Diez O, Domenech M, Alonso MC, Brunet J, Sanz J, et al. (1998) Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population. Hum Genet 103: 707-708.
37. Blesa JR, Garcia JA, Ochoa E, (2000) Frequency of germ-line BRCA1 mutations among Spanish families from a Mediterranean area. Hum Mutat 15: 381-382.
38. Osorio A, Barroso A, Martinez B, Cebrian A, San Roman JM, et al. (2000) Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families. British Journal of Cancer 82: 1266-1270.
39. Diez O, Osorio A, Robledo M, Barroso A, Domenech M, et al. (1999) Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients. Br J Cancer 79: 1302-1303.
40. Osorio A, Robledo M, Albertos J, Diez O, Alonso C, et al. (1998) Molecular analysis of the six most recurrent mutations in the BRCA1 gene in 87 Spanish breast/ovarian cancer families. Cancer Lett 123: 153-158.
41. Ah Mew N, Hamel N, Galvez M, Al-Saffar M, Foulkes WD, (2002) Haplotype analysis of a BRCA1: 185delAG mutation in a Chilean family supports its Ashkenazi origins. Clin Genet 62: 151-156.
42. Alvarez-Franco M LG, Gerson R, Bale AE, (2001) BRCA1 and BRCA2 founder mutations in Spanish and Mexican populations. Am J Hum Genet 69: A.
43. Mullineaux LG, Castellano TM, Shaw J, Axell L, Wood ME, et al. (2003) Identification of germline 185delAG BRCA1 mutations in non-Jewish Americans of Spanish ancestry from the San Luis Valley, Colorado. Cancer 98: 597-602.
44. Weitzel JN, Lagos V, Blazer KR, Nelson R, Ricker C, et al. (2005) Prevalence of BRCA mutations and founder effect in high-risk Hispanic families. Cancer Epidemiol Biomarkers Prev 14: 1666-1671.
45. Li R, Scanlon KS, Serdula MK, (2005) The validity and reliability of maternal recall of breastfeeding practice. Nutr Rev 63: 103-110.
46. Launer LJ, Forman MR, Hundt GL, Sarov B, Chang D, et al. (1992) Maternal recall of infant feeding events is accurate. J Epidemiol Community Health 46: 203-206.
47. Promislow JH, Gladen BC, Sandler DP, (2005) Maternal recall of breastfeeding duration by elderly women. Am J Epidemiol 161: 289-296.
48. Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, et al. (2008) Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4: e1000054.